![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 211/60 | (2006.01) |
C07D 401/06 | (2006.01) | ||
C07D 401/10 | (2006.01) | ||
C07D 401/14 | (2006.01) | ||
C07D 405/10 | (2006.01) | ||
C07D 413/12 | (2006.01) | ||
A61P 37/06 | (2006.01) | ||
A61K 31/445 | (2006.01) | ||
A61K 31/451 | (2006.01) | ||
A61K 31/4545 | (2006.01) | ||
A61K 31/5377 | (2006.01) |
(11) | Number of the document | 3508477 |
(13) | Kind of document | T |
(96) | European patent application number | 19154555.7 |
Date of filing the European patent application | 2009-12-21 | |
(97) | Date of publication of the European application | 2019-07-10 |
(45) | Date of publication and mention of the grant of the patent | 2021-11-10 |
(46) | Date of publication of the claims translation | 2022-02-10 |
(30) | Number | Date | Country code |
13991908 P | 2008-12-22 | US |
(72) |
FAN, Pingchen , US
GREENMAN, Kevin Lloyd , US
LELETI, Manmahon Reddy , US
LI, Yandong , US
POWERS, Jay , US
TANAKA, Hiroko , US
YANG, Ju , US
ZENG, Yibin , US
|
(73) |
ChemoCentryx, Inc.,
One Amgen Center Drive, Thousand Oaks CA 91320,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | C5AR antagonistai |
C5AR ANTAGONISTS |
Payment date | Validity (years) | Amount | |
2024-11-21 | 16 | 347.00 EUR |
2025-12-21 |